1 – 10 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Buserelin treatment to rats causes enteric neurodegeneration with moderate effects on CRF-immunoreactive neurons and Enterobacteriaceae in colon, and in acetylcholine-mediated permeability in ileum.
(
- Contribution to journal › Article
- 2014
-
Mark
Loss-of-Function of the Voltage-Gated Sodium Channel Na(V)1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome
(
- Contribution to journal › Article
-
Mark
Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome
(
- Contribution to journal › Article
- 2013
-
Mark
Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract.
(
- Contribution to journal › Article
-
Mark
Autoantibodies and gastrointestinal symptoms in infertile women in relation to in vitro fertilization
(
- Contribution to journal › Article
- 2012
-
Mark
Expression of Luteinizing Hormone Receptor in the Gastrointestinal Tract in Patients with and without Dysmotility.
(
- Contribution to journal › Article
-
Mark
Depletion of enteric gonadotropin-releasing hormone is found in a few patients suffering from severe gastrointestinal dysmotility.
(
- Contribution to journal › Article
- 2011
-
Mark
Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS)
(
- Contribution to journal › Article
-
Mark
Association of TNFSF15 polymorphism with irritable bowel syndrome
(
- Contribution to journal › Article
-
Mark
Oxytocin reduces satiety scores without affecting the volume of nutrient intake or gastric emptying rate in healthy subjects.
(
- Contribution to journal › Article